First report on echinocandin resistant Polish Candida isolates:

Martyna Mroczyńska; Anna Brillowska-Dabrowska

doi:10.18388/abp.2019_2826

First report on echinocandin resistant Polish Candida isolates

Echinocandin resistant Polish Candida isolates

Martyna Mroczyńska Gdańsk University of Technology, Faculty of Chemistry, Department of Molecular Biotechnology and Microbiology, Gdańsk, Poland https://orcid.org/0000-0002-6476-7580
Anna Brillowska-Dabrowska Gdańsk University of Technology, Faculty of Chemistry, Department of Molecular Biotechnology and Microbiology, Gdańsk, Poland https://orcid.org/0000-0002-7049-2536

DOI: https://doi.org/10.18388/abp.2019_2826

Abstract

Purpose: Candida spp. are ranked as one of the four major causative agents of fungal infections. The number of infections caused by Candida species resistant to fluconazole, which is applied as the first line drug in candidiasis treatment, increases every year. In such cases the application of echinocandin is necessary. Echinocandin susceptibility testing has become a routine laboratory practice in many countries due to the increasing frequency of clinical failures during treatment with these drugs. Methods: We performed anidulafungin, micafungin and caspofungin susceptibility testing according to the microdilution broth method on 240 Candida isolates collected in Polish hospitals. Results: We identified 12 isolates resistant to all echinocandins within 240 examined isolates. Moreover, 6 of the examined samples were identified as rare Candida species and among them we observed very high echinocandin MIC values. Conclusion: Our research proves that in Poland there is a problem of echinocandin resistance. Moreover, we identified two species of Candida which are rare causative agents of human infections, and there was no reported incidence of such infections in Poland until now.

pdf
html

Published

2019-09-12

Issue

Vol. 66 No. 3 (2019)

Section

Articles

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

Acta Biochimica Polonica is an open access quarterly and publishes four issues a year. All contents are distributed under the Creative Commons Attribution-ShareAlike 4.0 International (CC BY-SA 4.0) license. Everybody may use the content following terms: Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made, ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original. There are no additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.